Prozyme Inc

Fluidigm Corporation is a leading biotechnology company based in South San Francisco, CA. They specialize in developing innovative technologies and instruments for life sciences research, with a focus on imaging mass cytometry, mass cytometry, and microfluidics. Their cutting-edge products and services cater to various areas of interest, including genomics, immune profiling, infectious disease analysis, and single-cell analysis. With a strong commitment to scientific excellence and customer satisfaction, Fluidigm Corporation is dedicated to advancing research and discovery in the field of biotechnology. Fluidigm Corporation offers a wide range of instruments, kits, reagents, and software solutions to support diverse research needs. Their advanced technologies, such as the CyTOF XT, Helios, and Hyperion Imaging Systems, enable high-throughput genomics, spatial biology analysis, and immune profiling. Additionally, they provide comprehensive services, including scientific consultation, training, and custom assay design. With a focus on innovation and collaboration, Fluidigm Corporation continues to be a trusted partner for researchers and scientists worldwide.Generated from the website

Orthotrophix is a biotechnology company based in Oakland, CA, specializing in innovative research and development in the field of regenerative medicine. The company focuses on utilizing cutting-edge technology to create advanced solutions for tissue repair and regeneration, with a commitment to improving patient outcomes and quality of life. Generated from their business information

BioCheck is a leading provider of high-quality in vitro diagnostic products, including instruments, antibodies, and ELISA kits, designed to meet the highest standards of quality and specificity. With the recent acquisition of DRG International and its subsidiaries, BioCheck has expanded its global distribution capabilities, ensuring quick and reliable delivery of their products worldwide. Committed to transforming healthcare, BioCheck leverages technology and data to improve patient outcomes, reduce costs, and promote equitable access to care. Their value-based diagnostics approach empowers healthcare providers to make informed decisions and deliver personalized care, while their focus on well-established diagnostics enables early detection and intervention, ultimately saving lives and improving health outcomes.Generated from the website